After surgical hepatectomy, the remaining hepatic tissue quickly and efficiently proliferates, reconstituting the normal liver mass. Yet, under certain circumstances, for example, In the septic patient, regeneration does not effectively proceed and hepatic failure ensues. Hepatic regeneration Is known to be influenced by the hormonal environment. Evidence derived from recent studies suggests that the important growth hormone prolactin (PRL) is a potent regulator of hepatocyte mitogenesis. More recently, a 'second messenger' of prolactin action, protein kinase C (PKC), has been identified. PKC isoenzymes are modulated by membrane phospholipid products (i.e. diacylglycerol), calcium Ion, and membrane-associated serine protease. Activated PKC and perhaps also Its cleavage product PKM (which is likewise catalytically functional), in turn phosphorylate receptors, elicit gene expression, etc. This proposal seeks to define the roles of PRL and the PKC Isoenzymes in the mitogenesis which follows liver resection. Specifically, the very early (literally, within minutes) biochemical events 'priming' hepatocytes for regeneration will be defined under conditions of hypo- and euprolactinemia. Then, specific steps relating to the PKC activation sequence will be selectively inhibited In order to identify those which are critical to the successful execution of hepatocellular mitogenesis. A unique feature of this proposal is its exploitation of two recently developed models for the rapid, reproducible and efficient quantification of modulators of hepatocellular proliferation: (1) Isolated hepatocyte nuclei, in which prolactin rapidly induces a 300-400 fold activation of protein kinase C and which also respond to other mitogens, e.g. epidermal growth factor; and (2) precision cut liver slices, which maintain viability and biochemical responsiveness for up to several days after harvesting. From these studies an understanding of the first few minutes of liver regeneration, during which hepatocytes are primed for division, will emerge. Manipulating these biochemical events may well allow the successful initiation or augmentation of liver regeneration at times when it might otherwise falter, for example, after surgical resection or in multiple organ failure.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK042279-02
Application #
3243318
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Project Start
1991-08-01
Project End
1994-07-31
Budget Start
1992-08-01
Budget End
1993-07-31
Support Year
2
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Arizona
Department
Type
Schools of Medicine
DUNS #
City
Tucson
State
AZ
Country
United States
Zip Code
85721
Daller, J A; Buckley, A R; Van Hook, F W et al. (1994) Suramin, a protein kinase C inhibitor, impairs hepatic regeneration. Cell Growth Differ 5:761-7
Sawyer, J S; Daller, J A; Brendel, K et al. (1994) The hepatotoxicities of endotoxin and ethanol comparisons in vitro using the precision-cut rat liver slice model. Life Sci 55:1407-17
Bull, D A; Seftor, E A; Hendrix, M J et al. (1993) Putative vascular endothelial cell chemotactic factors: comparison in a standardized migration assay. J Surg Res 55:473-9
Buckley, A R; Montgomery, D W; Hendrix, M J et al. (1992) Identification of prolactin receptors in hepatic nuclei. Arch Biochem Biophys 296:198-206
Bull, D A; Hunter, G C; Copeland, J G et al. (1992) Peripheral vascular disease in heart transplant recipients. J Vasc Surg 16:546-53;discussion 553-4